title: [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
authors.forename: G
authors.initials: G
authors.lastname: Garozzo
authors.forename: G
authors.initials: G
authors.lastname: Granà
authors.forename: E
authors.initials: E
authors.lastname: Lomeo
authors.forename: M
authors.initials: M
authors.lastname: La Greca
authors.forename: M G
authors.initials: MG
authors.lastname: Castiglione
authors.forename: M
authors.initials: M
authors.lastname: Caruso
authors.forename: M
authors.initials: M
authors.lastname: Curatolo
authors.forename: P
authors.initials: P
authors.lastname: Gurgone
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
vernacular_title: Impiego della timopentina nel trattamento del carcinoma ovarico: risultati clinici preliminari.